Global Fund to Fight AIDS, Tuberculosis and Malaria: Landmark HIV Diagnostic Access Program Will Save $150m
“Roche has announced a major Global Access Program to sharply lower the price of HIV viral load tests in low- and middle-income countries. This new initiative creates a ceiling price of US$9.40 per test, and will reduce Roche’s average price by more than 40 percent in low- and middle-income countries. When fully implemented, the Global Access Program is projected to save more than US$150 million in costs over the next five years…” (9/26).